Additionally, insulin promotes cell proliferation and increased insulin, in addition to insulin-like growth factor 1 (IGF1) and IGF2 levels, critically stimulates tumour initiation and progression in insulin-resistant patients [1]. This evidence concerns the gene IGF1 and neoplasm.